Metabolic regulation of natural killer cells

Biochemical Society Transactions

Volumn 43, Issue , 2015, Pages 758-762

  Finlay, David K ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Glucose; Glycolysis; Immunometabolism; Mammalian target of rapamycin complex 1 (mTORC1); Natural killer cells

Indexed keywords

GLUCOSE; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MESSENGER RNA; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; TARGET OF RAPAMYCIN KINASE;

ARTICLE; CELL FUNCTION; CELL METABOLISM; CELLULAR IMMUNITY; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; IMMUNOCOMPETENT CELL; METABOLIC REGULATION; NATURAL KILLER CELL; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION; ANIMAL; COMPARATIVE STUDY; IMMUNOLOGY; METABOLISM;

MAMMALIA;

ANIMALS; GLYCOLYSIS; HUMANS; KILLER CELLS, NATURAL; MULTIPROTEIN COMPLEXES; NEOPLASMS; T-LYMPHOCYTES; TOR SERINE-THREONINE KINASES; VIRUS DISEASES;

EID: 84938781549     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20150116     Document Type: Article

References (38)

1. Vivier, E., Raulet, D.H., Moretta, A., Caligiuri, M.A., Zitvogel, L., Lanier, L.L., Yokoyama, W.M. and Ugolini, S. (2011) Innate or adaptive immunity? The example of natural killer cells. Science 331, 44-49 CrossRef PubMed
2. Lee, S.H., Fragoso, M.F. and Biron, C.A. (2012) Cutting edge: a novel mechanism bridging innate and adaptive immunity: IL-12 induction of CD25 to form high-affinity IL-2 receptors on NK cells. J. Immunol. 189, 2712-2716 CrossRef PubMed
3. Bihl, F., Pecheur, J., Breart, B., Poupon, G., Cazareth, J., Julia, V., Glaichenhaus, N. and Braud, V. M. (2010) Primed antigen-specific CD4+ T cells are required for NK cell activation in vivo upon Leishmania major infection. J. Immunol. 185, 2174-2181 CrossRef PubMed
4. Kerdiles, Y., Ugolini, S. and Vivier, E. (2013) T cell regulation of natural killer cells. J. Exp. Med. 210, 1065-1068 CrossRef PubMed
5. Pearce, E. L. and Pearce, E. J. (2013) Metabolic pathways in immune cell activation and quiescence. Immunity 38, 633-643 CrossRef PubMed
6. Wang, R., Dillon, C.P., Shi, L.Z., Milasta, S., Carter, R., Finkelstein, D., McCormick, L.L., Fitzgerald, P., Chi, H., Munger, J. and Green, D.R. (2011) The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35, 871-882 CrossRef PubMed
7. Donnelly, R.P., Loftus, R.M., Keating, S.E., Liou, K.T., Biron, C.A., Gardiner, C.M. and Finlay, D.K. (2014) mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function. J. Immunol. 193, 4477-4484 CrossRef PubMed
8. Marcais, A., Cherfils-Vicini, J., Viant, C., Degouve, S., Viel, S., Fenis, A., Rabilloud, J., Mayol, K., Tavares, A., Bienvenu, J. et al. (2014) The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat. Immunol. 15, 749-757 CrossRef PubMed
9. Everts, B., Amiel, E., Huang, S.C., Smith, A.M., Chang, C.H., Lam, W.Y., Redmann, V., Freitas, T.C., Blagih, J., van der Windt, G.J. et al. (2014) TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKvarepsilon supports the anabolic demands of dendritic cell activation. Nat. Immunol. 15, 323-332 CrossRef PubMed
10. Finlay, D.K., Rosenzweig, E., Sinclair, L.V., Feijoo-Carnero, C., Hukelmann, J.L., Rolf, J., Panteleyev, A.A., Okkenhaug, K. and Cantrell, D.A. (2012) PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells. J. Exp. Med. 209, 2441-2453 CrossRef PubMed
11. Sinclair, L., Rolf, J., Emslie, E., Shi, Y.B., Taylor, P.M. and Cantrell, D.A. (2013) Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat. Immunol. 14, 500-508 CrossRef PubMed
12. Keppel, M.P., Saucier, N., Mah, A.Y., Vogel, T.P. and Cooper, M.A. (2015) Activation-specific metabolic requirements for NK Cell IFN-gamma production. J. Immunol. 194, 1954-1962 CrossRef PubMed
13. Laplante, M. and Sabatini, D.M. (2012) mTOR signaling in growth control and disease. Cell 149, 274-293 CrossRef PubMed
14. Powell, J.D., Pollizzi, K.N., Heikamp, E.B. and Horton, M.R. (2011) Regulation of immune responses by mTOR. Annu. Rev. Immunol. 30, 39-68
15. Nandagopal, N., Ali, A.K., Komal, A.K. and Lee, S.H. (2014) The critical role of IL-15-PI3K-mTOR pathway in natural killer cell effector functions. Front. Immunol 5, 187 CrossRef PubMed
16. Yang, K. and Chi, H. (2012) mTOR and metabolic pathways in T cell quiescence and functional activation. Semin. Immunol. 24, 421-428 CrossRef PubMed
17. Amiel, E., Everts, B., Fritz, D., Beauchamp, S., Ge, B., Pearce, E.L. and Pearce, E.J. (2014) Mechanistic target of rapamycin inhibition extends cellular lifespan in dendritic cells by preserving mitochondrial function. J. Immunol. 193, 2821-2830 CrossRef PubMed
18. Frey, P.A. (1996) The Leloir pathway: a mechanistic imperative for three enzymes to change the stereochemical configuration of a single carbon in galactose. FASEB. J. 10, 461-470 PubMed
19. Chang, C.H., Curtis, J.D., Maggi, Jr, L.B., Faubert, B., Villarino, A.V., O'Sullivan, D., Huang, S.C., van der Windt, G.J., Blagih, J., Qiu, J. et al. (2013) Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153, 1239-1251 CrossRef PubMed
20. Gubser, P.M., Bantug, G.R., Razik, L., Fischer, M., Dimeloe, S., Hoenger, G., Durovic, B., Jauch, A. and Hess, C. (2013) Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch. Nat. Immunol. 14, 1064-1072 CrossRef PubMed
21. Sukumar, M., Liu, J., Ji, Y., Subramanian, M., Crompton, J.G., Yu, Z., Roychoudhuri, R., Palmer, D.C., Muranski, P., Karoly, E.D. et al. (2013) Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. J. Clin. Invest. 123, 4479-4488 CrossRef PubMed
22. Caro-Maldonado, A., Wang, R., Nichols, A.G., Kuraoka, M., Milasta, S., Sun, L.D., Gavin, A.L., Abel, E.D., Kelsoe, G., Green, D.R. and Rathmell, J.C. (2014) Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells. J. Immunol. 192, 3626-3636 CrossRef PubMed
23. Singh, R. and Green, M.R. (1993) Sequence-specific binding of transfer RNA by glyceraldehyde-3-phosphate dehydrogenase. Science 259, 365-368 CrossRef PubMed
24. Nagy, E. and Rigby, W.F. (1995) Glyceraldehyde-3-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD(+)-binding region (Rossmann fold). J. Biol. Chem. 270, 2755-2763 CrossRef PubMed
25. De, B.P., Gupta, S., Zhao, H., Drazba, J.A. and Banerjee, A.K. (1996) Specific interaction in vitro and in vivo of glyceraldehyde-3-phosphate dehydrogenase and LA protein with cis-acting RNAs of human parainfluenza virus type 3. J. Biol. Chem. 271, 24728-24735 CrossRef PubMed
26. Schultz, D. E., Hardin, C.C. and Lemon, S.M. (1996) Specific interaction of glyceraldehyde 3-phosphate dehydrogenase with the 5′-nontranslated RNA of hepatitis A virus. J. Biol. Chem. 271, 14134-14142 CrossRef PubMed
27. Zang, W.Q., Fieno, A.M., Grant, R.A. and Yen, T.S. (1998) Identification of glyceraldehyde-3-phosphate dehydrogenase as a cellular protein that binds to the hepatitis B virus posttranscriptional regulatory element. Virology 248, 46-52 CrossRef PubMed
28. Castello, A., Fischer, B., Eichelbaum, K., Horos, R., Beckmann, B.M., Strein, C., Davey, N.E., Humphreys, D.T., Preiss, T., Steinmetz, L.M. et al. (2012) Insights into RNA biology from an atlas of mammalian mRNA-binding proteins. Cell 149, 1393-1406 CrossRef PubMed
29. Rolf, J., Zarrouk, M., Finlay, D.K., Foretz, M., Viollet, B. and Cantrell, D.A. (2013) AMPKalpha1: a glucose sensor that controls CD8 T-cell memory. Eur. J. Immunol 43, 889-896 CrossRef PubMed
30. Munger, J., Bennett, B.D., Parikh, A., Feng, X.J., McArdle, J., Rabitz, H.A., Shenk, T. and Rabinowitz, J.D. (2008) Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat. Biotechnol. 26, 1179-1186 CrossRef PubMed
31. Piccoli, C., Quarato, G., Ripoli, M., D'Aprile, A., Scrima, R., Cela, O., Boffoli, D., Moradpour, D. and Capitanio, N. (2009) HCV infection induces mitochondrial bioenergetic unbalance: causes and effects. Biochim. Biophys. Acta 1787, 539-546 CrossRef PubMed
32. Ripoli, M., D'Aprile, A., Quarato, G., Sarasin-Filipowicz, M., Gouttenoire, J., Scrima, R., Cela, O., Boffoli, D., Heim, M.H., Moradpour, D. et al. (2010) Hepatitis C virus-linked mitochondrial dysfunction promotes hypoxia-inducible factor 1 alpha-mediated glycolytic adaptation. J. Virol. 84, 647-660 CrossRef PubMed
33. Thai, M., Graham, N.A., Braas, D., Nehil, M., Komisopoulou, E., Kurdistani, S.K., McCormick, F., Graeber, T.G. and Christofk, H.R. (2014) Adenovirus E4ORF1-induced MYC activation promotes host cell anabolic glucose metabolism and virus replication. Cell Metab 19, 694-701 CrossRef PubMed
34. Hirayama, A., Kami, K., Sugimoto, M., Sugawara, M., Toki, N., Onozuka, H., Kinoshita, T., Saito, N., Ochiai, A., Tomita, M. et al. (2009) Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 69, 4918-4925 CrossRef PubMed
35. Cham, C.M. and Gajewski, T.F. (2005) Metabolic mechanisms of tumor resistance to T cell effector function. Immunol. Res. 31, 107-118 CrossRef PubMed
36. Carrega, P., Morandi, B., Costa, R., Frumento, G., Forte, G., Altavilla, G., Ratto, G.B., Mingari, M.C., Moretta, L. and Ferlazzo, G. (2008) Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells. Cancer 112, 863-875 CrossRef PubMed
37. Mamessier, E., Sylvain, A., Thibult, M.L., Houvenaeghel, G., Jacquemier, J., Castellano, R., Goncalves, A., Andre, P., Romagne, F., Thibault, G. et al. (2011) Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J. Clin. Invest. 121, 3609-3622 CrossRef PubMed
38. Platonova, S., Cherfils-Vicini, J., Damotte, D., Crozet, L., Vieillard, V., Validire, P., Andre, P., Dieu-Nosjean, M.C., Alifano, M., Regnard, J.F. et al. (2011) Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma. Cancer Res 71, 5412-5422 CrossRef PubMed